- Report
- July 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- March 2025
- 183 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- March 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- August 2022
- 111 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- May 2023
- 160 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- April 2023
- 112 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- August 2022
- 115 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- January 2024
- 102 Pages
Global
From €3500EUR$3,944USD£3,043GBP
- Book
- February 2020
- 459 Pages
From €123EUR$129USD£103GBP
- Book
- September 2013
- 352 Pages
- Book
- June 2012
- 596 Pages
- Book
- December 2011
- 400 Pages
The Inflammatory Disease market within the context of Allergy and Immunology is a rapidly growing field of medicine. It focuses on the diagnosis and treatment of conditions caused by an overactive immune system, such as asthma, eczema, and food allergies. These conditions can be caused by environmental factors, genetics, or a combination of both. Treatment options include medications, lifestyle changes, and immunotherapy.
The Inflammatory Disease market is a highly competitive space, with many companies offering innovative treatments and therapies. Some of the major players in the market include AbbVie, AstraZeneca, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. These companies are constantly developing new treatments and therapies to improve the quality of life for those suffering from inflammatory diseases. Show Less Read more
